tiprankstipranks

Harlan Waksal Insider Profile

4 Followers
Harlan Waksal, Director at Eloxx Pharmaceuticals, holds 536.97K shares in Lyra Therapeutics (Ticker: LYRA), holds 0.00 shares in Kadmon Holdings (Ticker: KDMN), holds 2.81M shares in Eloxx Pharmaceuticals (Ticker: ELOX).
tipranks
Harlan Waksal

Harlan Waksal
Eloxx Pharmaceuticals (ELOX)
Director

Ranked #70,899 out of 99,635 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

-15.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
94.99%
5.01%
A breakdown of Harlan Waksal's holdings

Insider Roles

Eloxx Pharmaceuticals
(ELOX)
Director
Lyra Therapeutics
(LYRA)
Executive Chair, Director
Roles that Harlan Waksal holds in companies

Most Profitable Insider Trade

Stock:
Kadmon Holdings
(KDMN)
Rating:Informative Buy
Date:Mar 16, 2020 - Mar 16, 2021
Return:+63.60%
The most profitable trade made by Harlan Waksal

Harlan Waksal's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Eloxx Pharmaceuticals
Oct 05, 2012
Director
Informative Buy
223.21K
$1.94M
KDMN
Kadmon Holdings
Nov 09, 2021
Uninformative Sell
1.69M
$0.00
Lyra Therapeutics
Mar 20, 2024
Executive Chair, Director
Uninformative Buy
$102.02K
List of latest transactions for each holding click on a transaction to see Harlan Waksal's performance on stock

Harlan Waksal insider profile FAQ

What is the percentage of profitable transactions made by Harlan Waksal?
The percentage of profitable transactions made by Harlan Waksal is 50%.
    What is the average return per transaction made by Harlan Waksal?
    The average return per transaction made by Harlan Waksal is -15.60%.
      What stocks does Harlan Waksal hold?
      Harlan Waksal holds: ELOX, KDMN, LYRA stocks.
        What was Harlan Waksal’s latest transaction?
        Harlan Waksal latest transaction was an Uninformative Buy of ―.
          What was Harlan Waksal's most profitable transaction?
          Harlan Waksal’s most profitable transaction was an Informative Buy of KDMN stock on March 16, 2020. The return on the trade was 63.60%.
            What is Harlan Waksal's role in Eloxx Pharmaceuticals?
            Harlan Waksal's role in Eloxx Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.